Linganisha mbinu

	Kiwango cha Kujiamini kwa Matumizi Sahihi ya Dawa (SEAMS)	Kiwalajishaji cha Kuridhika na Matibabu kwa Ajili ya Dawa (TSQM)
Nyanja	Famakolojia	Famakolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2007	2004
Mwanzilishi	Gbenga Ogedegbe, Antoinette Schoenthaler, and colleagues	Mary Jo Atkinson and colleagues
Aina	Self-report	Self-report
Chanzo asilia	Ogedegbe, G., Schoenthaler, A., & Richardson, T. (2007). An Exploration of Contextual Factors and Antihypertensive Medication Adherence in Hypertensive African Americans. American Journal of Health-System Pharmacy, 64(23), 2510-2516. (SEAMS adapted from original research on self-efficacy in medication adherence.)	Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12.
Majina mbadala	SEAMS	TSQM
Zinazohusiana	4	4
Muhtasari	The Self-Efficacy for Appropriate Medication Use Scale (SEAMS) is a brief self-report measure designed to assess patients' confidence in their ability to manage medications appropriately across diverse contexts and challenges. Grounded in Bandura's self-efficacy theory, the SEAMS evaluates patients' perceived capacity to adhere to medication regimens despite potential barriers—forgetfulness, side effects, cost constraints, complexity, or changes in routine. The scale has demonstrated strong predictive validity for medication adherence and clinical outcomes in hypertension, diabetes, asthma, and other chronic diseases, making it valuable for identifying patients with low medication management confidence who need additional support.	The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies.